Clearance of ceftazidime during continuous venovenous haemofiltration in critically ill patients

Journal of Antimicrobial Chemotherapy

Volumn 49, Issue 1, 2002, Pages 129-134

  Traunmüller, Friederike ^a   Schenk, Peter ^a   Mittermeyer, Christoph ^a   Thalhammer Scherrer, Renate ^a   Ratheiser, Klaus ^a   Thalhammer, Florian ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; POLYSULFONE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DOSE CALCULATION; DOSE KIDNEY FUNCTION RELATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HEMOFILTRATION; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; PHARMACODYNAMICS; PROSPECTIVE STUDY; PUBLISHING;

EID: 0036156688     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/49.1.129     Document Type: Article

References (24)

1. Continuous infusion of beta-lactam antibiotics
2. Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model
3. Pharmacokinetic-pharmacodynamic modeling of activity of ceftazidime during continuous and intermittent infusion
4. Continuous infusion of β-lactam antibiotics
5. The pharmacodynamics of β-lactams
6. Role of pharmacokinetics in the outcome of infections
7. Pharmacokinetics of ceftazidime in normal and uremic subjects
8. Determinants of ceftazidime by continuous venovenous hemofiltration and continuous venovenous hemodialysis
9. Altered pharmacokinetics of ceftazidime in critically ill patients
10. Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected Gram-negative infections
11. Intermittent and continuous ceftazidime infusion for critically ill trauma patients
12. Intermittent bolus dosing of ceftazidime in critically ill patients
13. Effect of hemodialysis on ceftazidime pharmacokinetics
14. Pharmacokinetics of cefuroxime and ceftazidime in patients with acute renal failure treated by continuous arteriovenous haemodialysis
15. Multiple-dose pharmacokinetics of amikacin and ceftazidime in critically ill patients with septic multiple-organ failure during intermittent hemofiltration
16. Clinical pharmacokinetics during continuous haemofiltration
17. Single-dose pharmacokinetics of levofloxacin during continuous venovenous hemofiltration in critically ill patients
18. Assay of ceftazidime in biological fluids using high pressure liquid chromatography
19. Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration
20. In vitro activity of newer broad spectrum beta-lactam antibiotics against Enterobacteriaceae and non-fermenters. A report from Austrian intensive care units
21. Antimicrobial activity, pharmacokinetics, therapeutic indications and adverse reactions of ceftazidime
22. The pharmacokinetics of ceftazidime during hemodiafiltration in critically ill patients
23. Removal of cephalosporins by continuous arteriovenous ultrafiltration (CAVU) and hemofiltration (CAVH)
24. Pharmacokinetics of ceftazidime in patients with renal insufficiency and in those undergoing hemodialysis